254 related articles for article (PubMed ID: 3308719)
1. Multicenter double-blind randomized clinical trial of imidazole salicylate versus ibuprofen in patients with rheumatoid arthritis.
DiPerri T; Auteri A; Fumagalli M; Gandini R; Giordano A; Giordano M; Scaricabarozzi I; Vaiani G; Vatti M
Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):443-7. PubMed ID: 3308719
[TBL] [Abstract][Full Text] [Related]
2. Multicenter double-blind randomized clinical trial of imidazole salicylate versus ibuprofen in patients with osteoarthrosis.
Di Perri T; Auteri A; Caruso I; Corvetta A; Danieli G; Sarzi Puttini PC; Scaricabarozzi I
Int J Clin Pharmacol Ther Toxicol; 1987 Sep; 25(9):479-82. PubMed ID: 3316058
[TBL] [Abstract][Full Text] [Related]
3. Double-blind randomized clinical trial on imidazole salicylate vs ibuprofen in osteoarthritis.
Kaik B; Bauer K; Bröll H
Int J Clin Pharmacol Ther Toxicol; 1991 May; 29(5):173-7. PubMed ID: 2071268
[TBL] [Abstract][Full Text] [Related]
4. Controlled clinical trial of imidazole.2-hydroxybenzoate (ITF 182) versus sulindac in patients with rheumatoid arthritis.
Fumagalli M; Cunietti E; Vaiani G; Monti M; Ferrari F; Gandini R
Clin Ther; 1986; 8(3):292-300. PubMed ID: 3521858
[TBL] [Abstract][Full Text] [Related]
5. Etodolac versus diclofenac: double-blind cross-over study in rheumatoid arthritis.
Ciompi ML; Puccetti L; Bazzichi L; Remorini E; Marotta G
Int J Clin Pharmacol Res; 1989; 9(3):217-22. PubMed ID: 2526101
[TBL] [Abstract][Full Text] [Related]
6. Double-blind cross-over study of indoprofen versus ibuprofen and placebo in rheumatoid arthritis patients.
Scali JJ; Rivelis L
Eur J Rheumatol Inflamm; 1981; 4(1):93-6. PubMed ID: 7042368
[TBL] [Abstract][Full Text] [Related]
7. A 12-week, double-blind, multicenter study comparing diflunisal twice daily and ibuprofen four times daily in the treatment of rheumatoid arthritis.
Bennett RM
Clin Ther; 1986; 9 Suppl C():27-36. PubMed ID: 3548984
[TBL] [Abstract][Full Text] [Related]
8. Results of a double-blind study with indomethacin and indoprofen, a new non-steroidal antirheumatic agent.
Seigmund H; Schneider B
Eur J Rheumatol Inflamm; 1981; 4(1):79-86. PubMed ID: 7042366
[TBL] [Abstract][Full Text] [Related]
9. A double-blind, comparative study of diflunisal and naproxen in the treatment of rheumatoid arthritis.
Devereaux MD; Douglas WA
Eur J Rheumatol Inflamm; 1983; 6(3):274-8. PubMed ID: 6391932
[TBL] [Abstract][Full Text] [Related]
10. A comparison of sulindac with ibuprofen in the management of rheumatoid arthritis.
Burry HC; Witherington L
N Z Med J; 1979 Apr; 89(634):298-300. PubMed ID: 377154
[TBL] [Abstract][Full Text] [Related]
11. A double-blind randomised controlled trial of droxicam versus indomethacin in rheumatoid arthritis.
Sánchez Andrada S; Rodríguez Valverde V
Eur J Rheumatol Inflamm; 1991; 11(4):15-20. PubMed ID: 1365485
[TBL] [Abstract][Full Text] [Related]
12. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model.
Litkowski LJ; Christensen SE; Adamson DN; Van Dyke T; Han SH; Newman KB
Clin Ther; 2005 Apr; 27(4):418-29. PubMed ID: 15922815
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of piroxicam and ibuprofen in rheumatoid arthritis.
Alam MN; Kabir MZ
Bangladesh Med Res Counc Bull; 1983 Dec; 9(2):54-9. PubMed ID: 6609700
[TBL] [Abstract][Full Text] [Related]
15. Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
Rabeneck L; Goldstein JL; Vu A; Mayne TJ; Rublee DA
Am J Gastroenterol; 2005 May; 100(5):1043-50. PubMed ID: 15842577
[TBL] [Abstract][Full Text] [Related]
16. Double-blind randomized trial of diclofenac sodium versus placebo in patients with rheumatoid arthritis.
Weisman MH
Clin Ther; 1986; 8(4):427-38. PubMed ID: 3524843
[TBL] [Abstract][Full Text] [Related]
17. Tolerability profile of the antiinflammatory compound imidazole salicylate: a metanalysis of safety data in 1408 patients.
Schiassi M; Bianchini C; Restelli A; Zoni G
Int J Tissue React; 1989; 11(6):321-6. PubMed ID: 2699882
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
[TBL] [Abstract][Full Text] [Related]
19. Arthritis: anti-inflammatory drugs in practice.
Dieppe P; Doyle D; Jacoby R
Practitioner; 1981 Mar; 225(1353):397-9. PubMed ID: 7022432
[No Abstract] [Full Text] [Related]
20. [Controlled clinical study of the clinical efficacy and tolerability of a new nonsteroidal anti-inflammatory preparation, imidazole-2-hydroxybenzoate, in patients with pain and phlogistic syndromes of varying etiopathogenesis].
Ginesu F; Schena G; Polo F; Deiola G; Ortu AR
Boll Chim Farm; 1983 Dec; 122(12):37S-49S. PubMed ID: 6372833
[No Abstract] [Full Text] [Related]
[Next] [New Search]
